長期投資家のためのIR情報
バリュートレンド

【4092】日本化学工業
工業薬品。
類似企業:


東証プライム
化学
>
化学
売上高
営業利益
経常利益
当期利益
{{models[key].tabname}}
決算期 日付 予・実 売上高
(百万円)
対前回 修正率 修正率 営業利益
(百万円)
対前回 修正率 修正率 経常利益
(百万円)
対前回 修正率 修正率 当期利益
(百万円)
対前回 修正率 修正率
2027.03 2026/08/10 Q1予 40,800 → 0.0% 0.0% 2,800 → 0.0% 0.0% 2,700 → 0.0% 0.0% 4,500 ↑ +50.0% +50.0%
2027.03 2026/05/13 当初予 40,800 - - - 2,800 - - - 2,700 - - - 3,000 - - -
2026.03 2026/05/13 実 40,182 ↓ -0.8% +3.0% 2,415 ↓ -24.5% +72.5% 2,375 ↓ -25.8% +69.6% 2,894 ↑ +11.3% +163.1%
2026.03 2026/02/10 Q3予 40,500 → 0.0% +3.8% 3,200 → 0.0% +128.6% 3,200 → 0.0% +128.6% 2,600 → 0.0% +136.4%
2026.03 2025/11/11 Q2予 40,500 → 0.0% +3.8% 3,200 → 0.0% +128.6% 3,200 → 0.0% +128.6% 2,600 → 0.0% +136.4%
2026.03 2025/08/07 Q1予 40,500 ↑ +3.8% +3.8% 3,200 ↑ +128.6% +128.6% 3,200 ↑ +128.6% +128.6% 2,600 ↑ +136.4% +136.4%
2026.03 2025/05/14 当初予 39,000 - - - 1,400 - - - 1,400 - - - 1,100 - - -
2025.03 2025/05/14 実 38,843 ↓ -2.9% -2.9% 3,342 ↓ -7.2% +15.2% 3,199 ↓ -11.1% +10.3% 2,559 ↓ -1.6% +28.0%
2025.03 2025/02/13 Q3予 40,000 → 0.0% 0.0% 3,600 → 0.0% +24.1% 3,600 → 0.0% +24.1% 2,600 → 0.0% +30.0%
2025.03 2024/11/12 修正予 40,000 → 0.0% 0.0% 3,600 ↑ +24.1% +24.1% 3,600 ↑ +24.1% +24.1% 2,600 ↑ +30.0% +30.0%
2025.03 2024/08/06 Q1予 40,000 → 0.0% 0.0% 2,900 → 0.0% 0.0% 2,900 → 0.0% 0.0% 2,000 → 0.0% 0.0%
2025.03 2024/05/14 当初予 40,000 - - - 2,900 - - - 2,900 - - - 2,000 - - -
2024.03 2024/05/14 実 38,538 ↑ +1.4% -3.7% 2,264 ↑ +7.8% +41.5% 2,383 ↑ +8.3% +48.9% 1,590 ↑ +6.0% +59.0%
2024.03 2024/04/09 修正予 38,000 ↓ -5.0% -5.0% 2,100 ↑ +31.3% +31.3% 2,200 ↑ +37.5% +37.5% 1,500 ↑ +50.0% +50.0%
2024.03 2024/02/08 Q3予 40,000 → 0.0% 0.0% 1,600 → 0.0% 0.0% 1,600 → 0.0% 0.0% 1,000 → 0.0% 0.0%
2024.03 2023/11/10 Q2予 40,000 → 0.0% 0.0% 1,600 → 0.0% 0.0% 1,600 → 0.0% 0.0% 1,000 → 0.0% 0.0%
2024.03 2023/08/09 Q1予 40,000 → 0.0% 0.0% 1,600 → 0.0% 0.0% 1,600 → 0.0% 0.0% 1,000 → 0.0% 0.0%
2024.03 2023/05/11 当初予 40,000 - - - 1,600 - - - 1,600 - - - 1,000 - - -
2023.03 2023/05/11 実 38,075 ↑ +0.2% +0.2% 1,292 ↓ -0.6% -38.5% 1,412 ↑ +0.9% -35.8% 855 ↓ -5.0% -38.9%
2023.03 2023/04/20 修正予 38,000 → 0.0% 0.0% 1,300 ↓ -38.1% -38.1% 1,400 ↓ -36.4% -36.4% 900 ↓ -35.7% -35.7%
2023.03 2023/02/10 Q3予 38,000 → 0.0% 0.0% 2,100 → 0.0% 0.0% 2,200 → 0.0% 0.0% 1,400 → 0.0% 0.0%
2023.03 2022/11/10 Q2予 38,000 → 0.0% 0.0% 2,100 → 0.0% 0.0% 2,200 → 0.0% 0.0% 1,400 → 0.0% 0.0%
2023.03 2022/08/09 Q1予 38,000 → 0.0% 0.0% 2,100 → 0.0% 0.0% 2,200 → 0.0% 0.0% 1,400 → 0.0% 0.0%
2023.03 2022/05/12 当初予 38,000 - - - 2,100 - - - 2,200 - - - 1,400 - - -
2022.03 2022/05/12 実 37,275 ↑ +3.5% +3.5% 3,921 ↓ -2.0% -2.0% 3,864 ↓ -3.4% -3.4% 3,735 ↑ +43.7% +43.7%
2022.03 2022/02/08 Q3予 36,000 → 0.0% 0.0% 4,000 → 0.0% 0.0% 4,000 → 0.0% 0.0% 2,600 → 0.0% 0.0%
2022.03 2021/11/10 Q2予 36,000 → 0.0% 0.0% 4,000 → 0.0% 0.0% 4,000 → 0.0% 0.0% 2,600 → 0.0% 0.0%
2022.03 2021/08/11 当初予 36,000 - - - 4,000 - - - 4,000 - - - 2,600 - - -
2021.03 2021/05/13 実 34,642 ↑ +1.9% +5.0% 2,783 ↑ +7.0% +131.9% 2,315 ↓ -11.0% +92.9% 2,182 ↑ +21.2% +172.8%
2021.03 2021/02/10 Q3予 34,000 ↑ +3.0% +3.0% 2,600 ↑ +116.7% +116.7% 2,600 ↑ +116.7% +116.7% 1,800 ↑ +125.0% +125.0%
2021.03 2020/11/10 Q2予 33,000 → 0.0% 0.0% 1,200 → 0.0% 0.0% 1,200 → 0.0% 0.0% 800 → 0.0% 0.0%
2021.03 2020/08/05 当初予 33,000 - - - 1,200 - - - 1,200 - - - 800 - - -
2020.03 2020/05/15 実 36,243 ↓ -3.4% -3.4% 2,481 ↓ -20.0% -20.0% 2,545 ↓ -17.9% -17.9% 1,857 ↓ -15.6% -15.6%
2020.03 2020/02/06 Q3予 37,500 → 0.0% 0.0% 3,100 → 0.0% 0.0% 3,100 → 0.0% 0.0% 2,200 → 0.0% 0.0%
2020.03 2019/11/08 Q2予 37,500 → 0.0% 0.0% 3,100 → 0.0% 0.0% 3,100 → 0.0% 0.0% 2,200 → 0.0% 0.0%
2020.03 2019/08/09 Q1予 37,500 → 0.0% 0.0% 3,100 → 0.0% 0.0% 3,100 → 0.0% 0.0% 2,200 → 0.0% 0.0%
2020.03 2019/05/14 当初予 37,500 - - - 3,100 - - - 3,100 - - - 2,200 - - -
2019.03 2019/05/14 実 36,157 ↓ -2.3% -2.3% 3,084 ↓ -9.3% -9.3% 3,057 ↓ -10.1% -10.1% 2,154 ↓ -6.3% -6.3%
2019.03 2019/02/08 Q3予 37,000 → 0.0% 0.0% 3,400 → 0.0% 0.0% 3,400 → 0.0% 0.0% 2,300 → 0.0% 0.0%
2019.03 2018/11/07 Q2予 37,000 → 0.0% 0.0% 3,400 → 0.0% 0.0% 3,400 → 0.0% 0.0% 2,300 → 0.0% 0.0%
2019.03 2018/08/07 Q1予 37,000 → 0.0% 0.0% 3,400 → 0.0% 0.0% 3,400 → 0.0% 0.0% 2,300 → 0.0% 0.0%
2019.03 2018/05/14 当初予 37,000 - - - 3,400 - - - 3,400 - - - 2,300 - - -
2018.03 2018/05/14 実 36,798 ↑ +2.2% +5.1% 4,084 ↑ +20.1% +63.4% 4,009 ↑ +17.9% +74.3% 2,774 ↑ +15.6% +73.4%
2018.03 2018/02/08 Q3予 36,000 ↑ +2.9% +2.9% 3,400 ↑ +36.0% +36.0% 3,400 ↑ +47.8% +47.8% 2,400 ↑ +50.0% +50.0%
2018.03 2017/11/06 Q2予 35,000 → 0.0% 0.0% 2,500 → 0.0% 0.0% 2,300 → 0.0% 0.0% 1,600 → 0.0% 0.0%
2018.03 2017/08/08 Q1予 35,000 → 0.0% 0.0% 2,500 → 0.0% 0.0% 2,300 → 0.0% 0.0% 1,600 → 0.0% 0.0%
2018.03 2017/05/11 当初予 35,000 - - - 2,500 - - - 2,300 - - - 1,600 - - -
2017.03 2017/05/11 実 33,484 ↓ -1.5% -7.0% 3,336 ↓ -4.7% -4.7% 3,460 ↑ +0.3% +0.3% 2,557 ↑ +2.3% +2.3%
2017.03 2017/02/07 Q3予 34,000 → 0.0% -5.6% 3,500 → 0.0% 0.0% 3,450 → 0.0% 0.0% 2,500 → 0.0% 0.0%
2017.03 2016/11/08 Q2予 34,000 ↓ -5.6% -5.6% 3,500 → 0.0% 0.0% 3,450 → 0.0% 0.0% 2,500 → 0.0% 0.0%
2017.03 2016/05/10 当初予 36,000 - - - 3,500 - - - 3,450 - - - 2,500 - - -
2016.03 2016/05/10 実 35,966 ↓ -0.1% +2.8% 3,452 ↑ +15.1% +15.1% 3,403 ↑ +17.3% +100.2% 2,464 ↑ +12.0% +89.5%
2016.03 2016/02/09 Q3予 36,000 → 0.0% +2.9% 3,000 → 0.0% 0.0% 2,900 → 0.0% +70.6% 2,200 → 0.0% +69.2%
2016.03 2015/11/10 Q2予 36,000 → 0.0% +2.9% 3,000 → 0.0% 0.0% 2,900 → 0.0% +70.6% 2,200 → 0.0% +69.2%
2016.03 2015/08/04 Q1予 36,000 ↑ +2.9% +2.9% 3,000 - - - 2,900 ↑ +70.6% +70.6% 2,200 ↑ +69.2% +69.2%
2016.03 2015/05/12 当初予 35,000 - - - - - - - 1,700 - - - 1,300 - - -
2015.03 2015/05/12 実 - - - - - - - - - - - - - - - -
2015.03 2015/02/10 Q3予 36,000 → 0.0% 0.0% 1,600 ↑ +23.1% +100.0% 1,500 ↑ +25.0% +150.0% 1,000 → 0.0% +100.0%
2015.03 2014/11/11 修正予 36,000 → 0.0% 0.0% 1,300 ↑ +44.4% +62.5% 1,200 ↑ +71.4% +100.0% 1,000 ↑ +25.0% +100.0%
2015.03 2014/08/05 修正予 36,000 → 0.0% 0.0% 900 ↑ +12.5% +12.5% 700 ↑ +16.7% +16.7% 800 ↑ +60.0% +60.0%
2015.03 2014/05/13 当初予 36,000 - - - 800 - - - 600 - - - 500 - - -
2014.03 2014/05/13 実 36,195 ↑ +0.5% +0.5% 859 ↑ +43.2% +43.2% 823 ↑ +37.2% +37.2% 672 ↑ +12.0% +12.0%
2014.03 2014/02/12 当初予 36,000 - - - 600 - - - 600 - - - 600 - - -
シェア ツイート
ページトップへ戻る